Shandong Kaisheng New MaterialsLtd Résultats passés
Passé contrôle des critères 1/6
Shandong Kaisheng New MaterialsLtd's earnings have been declining at an average annual rate of -0.5%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 10.8% per year. Shandong Kaisheng New MaterialsLtd's return on equity is 4.6%, and it has net margins of 8%.
Informations clés
-0.5%
Taux de croissance des bénéfices
-15.1%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.1% |
| Taux de croissance des recettes | 10.8% |
| Rendement des fonds propres | 4.6% |
| Marge nette | 8.0% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
We Think That There Are More Issues For Shandong Kaisheng New MaterialsLtd (SZSE:301069) Than Just Sluggish Earnings
Nov 01
Shandong Kaisheng New Materials Co.,Ltd.'s (SZSE:301069) Shares Climb 27% But Its Business Is Yet to Catch Up
Sep 30Unpleasant Surprises Could Be In Store For Shandong Kaisheng New Materials Co.,Ltd.'s (SZSE:301069) Shares
Jun 26Here's Why Shandong Kaisheng New MaterialsLtd (SZSE:301069) Has A Meaningful Debt Burden
May 13Shandong Kaisheng New MaterialsLtd (SZSE:301069) Could Be Struggling To Allocate Capital
Apr 12After Leaping 28% Shandong Kaisheng New Materials Co.,Ltd. (SZSE:301069) Shares Are Not Flying Under The Radar
Mar 07Ventilation des recettes et des dépenses
Comment Shandong Kaisheng New MaterialsLtd gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 955 | 77 | 73 | 53 |
| 30 Jun 24 | 990 | 109 | 74 | 51 |
| 31 Mar 24 | 979 | 133 | 74 | 48 |
| 31 Dec 23 | 987 | 158 | 74 | 52 |
| 30 Sep 23 | 978 | 179 | 76 | 60 |
| 30 Jun 23 | 979 | 206 | 75 | 62 |
| 31 Mar 23 | 1,001 | 216 | 71 | 59 |
| 31 Dec 22 | 1,010 | 235 | 66 | 54 |
| 30 Sep 22 | 1,039 | 241 | 62 | 50 |
| 30 Jun 22 | 1,004 | 230 | 58 | 45 |
| 31 Mar 22 | 941 | 211 | 53 | 45 |
| 01 Jan 22 | 880 | 193 | 48 | 43 |
| 30 Sep 21 | 759 | 161 | 51 | 38 |
| 31 Mar 21 | 677 | 168 | 69 | 32 |
| 31 Dec 20 | 624 | 160 | 78 | 30 |
| 30 Sep 20 | 637 | 186 | 140 | 43 |
| 30 Jun 20 | 642 | 187 | 80 | 26 |
| 31 Mar 20 | 631 | 154 | 86 | 26 |
| 31 Dec 19 | 659 | 137 | 78 | 26 |
| 30 Sep 19 | 656 | 106 | 23 | 5 |
| 30 Jun 19 | 676 | 84 | 98 | 22 |
| 31 Mar 19 | 677 | 74 | 90 | 21 |
| 31 Dec 18 | 677 | 64 | 56 | 19 |
| 30 Sep 18 | 629 | 65 | 83 | 18 |
| 30 Jun 18 | 629 | 65 | 84 | 18 |
| 31 Mar 18 | 551 | 71 | 80 | 16 |
| 31 Dec 17 | 449 | 78 | 52 | 14 |
| 30 Sep 17 | 412 | 76 | 74 | 9 |
| 30 Jun 17 | 352 | 74 | 74 | 5 |
| 31 Mar 17 | 329 | 66 | 74 | 2 |
| 31 Dec 16 | 307 | 58 | 74 | 0 |
| 31 Dec 15 | 238 | 44 | 48 | 0 |
Des revenus de qualité: 301069 has high quality earnings.
Augmentation de la marge bénéficiaire: 301069's current net profit margins (8%) are lower than last year (18.3%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 301069's earnings have declined by 0.5% per year over the past 5 years.
Accélération de la croissance: 301069's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 301069 had negative earnings growth (-57.3%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Rendement des fonds propres
ROE élevé: 301069's Return on Equity (4.6%) is considered low.